Xarelto Lawsuit Plaintiffs Allege Drug Puts Patients At Risk For Serious Bleeding Episodes

June 21, 2016 – – TheProductLawyers.com reports on the increased number of lawsuits regarding the blood thinner, Xarelto. Following its FDA approval in 2011, it became a popular treatment for patients suffering from pulmonary embolism or deep vein thrombosis. Physicians also used it to prevent strokes and the formation of blood clots in the legs of those recovering from knee or hip surgery. Because it did not require extensive monitoring, dosage adjustment, or changes in diet, many consumers felt it was a better choice than other anticoagulant treatments.

However, as its use became widespread, troubling symptoms developed. The FDA issued two black box warnings to Xarelto, which precede a complete product recall. Several patients reported that if they suddenly stopped using the drug or did not replace it with another anticoagulant therapy, they had a tendency to develop blood clots. Studies conducted following the first signs of alarm also showed that those switching to a Xarelto regimen from another therapy frequently developed bleeding from the eyes or stomach as a result.

Bayer AG and Janssen Pharmaceuticals are the subjects of more than 3,000 lawsuits. Due to similarities in allegations and the massive number of plaintiffs, the U.S. Judicial Panel for Multidistrict Litigation has consolidated 2,800 suits into MDL No. 2592. The Court of Common Pleas in Philadelphia, Pennsylvania has also consolidated suits into a mass tort program, comprising 550 cases.

MDL No. 2592 against Bayer AG and Janssen Pharmaceuticals alleges that the companies promoted the positive attributes of the drug, while using unsound business practices to conceal the negative side effects. Further, they claim that the companies placed individuals at increased risk for sudden and potentially deadly bleeding events.

Four bellwether trials are slated to begin in the first months of 2017. During the months of December 2015 and January 2016, there was extensive preparation for these trials. Any and all developments related to the 2017 trials will be reviewed in monthly status conferences.

The attorneys of Banville Law, the firm behind TheProductLawyers.com, are offering complimentary consultations to anyone who suffered injury or hospitalization after a bleed while on Xarelto. For more information about this release or the Xarelto litigation call 888-997-3792.

###

Contact TheProductLawyers.com:

Banville Law
888-997-3792
info@banvillelaw.com
165 West End Ave #1h,
New York, NY 10023

ReleaseID: 60010927